March 2013
Fox News America Live
March 5
Study: Late Stage Breast Cancer on the Rise in Younger Women – By Megyn Kelly
A new study reveals late stage breast cancer in women aged 25-39. Freya Schnabel, MD, is interviewed about the significance of the study.
-Freya Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Health.com
March 5
4 New Ways to Get Screened for Colon Cancer – By Amanda Gardner
March is National Colorectal Cancer Awareness Month so the spotlight is once again on screening for this often preventable cancer. Included in the article are ways researchers are trying to improve on the standard colonoscopy. Seth Gross, MD, is quoted.
-Seth Gross, MD, assistant professor, Department of Medicine, Division of Gastroenterology
Read more: http://news.health.com/2013/03/05/4-new-ways-to-get-screened-for-colon-cancer/ [1]
Everyday Health
March 5
Nagging Improves Colorectal Cancer Screening Rates, Study Finds – By Jessica Firger
Good old-fashioned nagging, made more efficient with the help of electronic medical records (EMRs), may be the key to encouraging more people to get colorectal cancer screenings like colonoscopy, according to a large new study published in the Annals of Internal Medicine. Seth Gross, MD comments on the importance of face-to-face contact with patients in addition to using EMRs.
-Seth Gross, MD, assistant professor, Department of Medicine, Division of Gastroenterology
Read more: http://www.everydayhealth.com/colon-cancer/nagging-improves-colorectal-cancer-screening-study-says.aspx [2]
New York Times
March 13
Radiation Raises Women’s Risk of Heart Disease Only Slightly, Study Finds – By Denise Grady
Researchers have found that the benefits to women in treating breast cancer with radiation outweigh the risks of heart disease. Silvia Formenti, MD, is interviewed about a technique she and her colleagues use to protect the heart and lungs from radiation during radiotherapy for breast cancer.
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
Read more: http://www.nytimes.com/2013/03/14/health/radiation-modestly-raises-womens-heart-risks-study-says.html?pagewanted=all [3]
Today Show
March 14
Colon Cancer Symptoms and Treatment – By Kathie Lee Gifford and Hoda Kotb
Mark Pochapin, MD, provides insight into colon cancer and the importance of getting screened early with a colonoscopy to prevent the disease before it progresses. Two patients with colon cancer are profiled.
-Mark Pochapin, MD, professor, Department of Medicine, Division of Gastroenterology
Gastroenterology and Endoscopy News
March 2013
What’s New in Colon Cancer Screening? - By Rebecca Felsenthal Stewart
New technology in colon cancer screening will make it easier for physicians to spot markers of the disease. Mark Pochapin, MD, is quoted.
-Mark Pochapin, MD, professor, Department of Medicine, Division of Gastroenterology
CBS Newspath
Story also appeared on CBS News Affiliates WLNY (New York), KUTV.com (Utah), KREX-CBS (Colorado), WTYV-CBS (Alabama), KMEG-CBS (Iowa), KRCG-CBS (Missouri), KFDA-CBS (Texas), KEPR-CBS (Washington), WMBD-CBS (Illinois), WANE-CBS (Indiana), KTVN-CBS (Nevada), WNCT-CBS (North Carolina), WISC-CBS (Wisconsin), KOLD-CBS (Arizona), KOTV-CBS (Oklahoma), WTKR-CBS (Virginia), WHP-CBS (Pennsylvania), WPEC-CBS (Florida)
March 18
Older Women Can Be Screened For Breast Cancer Less Often
How often women should be screened for breast cancer has been a big debate in recent years. Now a new study suggests some older women can safely be screened for breast cancer less often. Freya Schnabel, MD, is interviewed.
-Freya R. Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: http://www.kutv.com/health/features/check-health/stories/vid_313.shtml [4]
SociallySuperlative.com
March 18
Adults in Toyland Casino Night: Benefit for the Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders and KiDS of NYU Langone
“Adults in Toyland Casino Night” event raised $736,000 in funds to support children’s health services, including psychosocial and emotional support services provided at the Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders and the Department of Pediatrics. Photographs from the event are included.
-Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders
-Department of Pediatrics
Read more: http://sociallysuperlative.com/2013/03/18/adults-in-toyland-casino-night-benefit-for-the-stephen-d-hassenfeld-childrens-center-for-cancer-and-blood-disorders-and-kids-of-nyu-langone/ [5]
WLNY
March 21
Cancer Awareness – By Katie McGee
Mark Pochapin, MD, is interviewed about the importance of early diagnosis of colorectal cancer for prevention and treatment of the disease. Dr. Pochapin also describes the symptoms.
-Mark Pochapin, MD, the Sholtz/Leeds Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology
Reuters
Syndicated Reuters article also appeared on ChicagoTribune.com, Yahoo! News, OrlandoSentinel.com, WNFL.com, 929WLMI.com
March 21
Study Finds No Constipation, Colon Cancer Link – By Trevor Stokes
Long-term constipation doesn't raise risk for colon and rectal cancers according to a new analysis of the existing evidence. Seth Gross, MD, is quoted.
-Seth Gross, MD, assistant professor, Department of Medicine, Division of Gastroenterology
Read more: http://www.reuters.com/article/2013/03/21/us-study-constipation-cancer-idUSBRE92K0TU20130321 [6]
WCBS 2 News
Also covered by KUTV.com, WOWK.com, Fox affiliate in Madison, WI, WCBS affiliates in Palm Beach FL, Norfolk, VA, Providence, RI, Dayton, OH, Syracuse, NY, Brownsville, TX, Murtle Beach, SC, Fort Wayne, IN, Kennewick, WA, San Luis Obispo/Santa Barbara, CA, Wausau, WI, Jefferson City, MO, Lubbock, TX, Sioux City, IA, Bismarck, ND, Grand Junction, CO, Salem, NC, Madison, WI, Kearney, NE
March 27
Genetic Tests Helping To Pinpoint Those at Risk for Cancer – By Max Gomez
Researchers around the world are publishing more than a dozen studies that could help scientists pinpoint who is at increased risk for cancer. Scientists looked at the genetic tests of 200,000 people and uncovered dozens of markers on DNA that can help pinpoint those at risk. Kathie-Ann Joseph, MD provides commentary.
-Kathie-Ann Joseph, MD, assistant professor, Department of Surgery, Division of Breast Surgery
Read article: http://www.kutv.com/health/features/check-health/stories/vid_321.shtml [7]
Your News Now (YNN)
Also picked up by YNN affiliates in Albany/Schenectady, NY, Binghamton, NY, Watertown, NY
March 27
Healthy Living: Colon Cancer Screenings Can Be A Life Saver, Doctors Say – By Erin Billups, NY1
Approximately 1,400 New Yorkers die of colorectal cancer each year, and now with an annual awareness push under way, New York City and its hospitals are trying to bring that number down significantly. Mark Pochapin, MD, provides insight into the disease and why getting screened early for a colonoscopy is so important in preventing colon cancer.
-Mark Pochapin, MD, Sholtz/Leeds Professor of Gastroenterology, Department of Medicine, Division of Gastroenterology
Read more: http://centralny.ynn.com/content/health/healthy_living/650863/healthy-living--colon-cancer-screenings-can-be-a-life-saver--doctors-say/ [8]
GymTalkingClothing.com
March 27
Mammograms: What’s Best For Your Breasts?
Last November, the U.S. Preventive Services Task Force (USPSTF) recommended that women swap their after 40 annual mammograms for biannual ones starting at 50, and quit breast self-exams altogether. Karen Hiotis, MD, is quoted.
-Karen Hiotis, MD, assistant professor, Department of Surgery, Divisions of Breast Surgery and Surgical Oncology
Read more: http://www.gymtalkclothing.com/news-and-tips/mammograms-whats-best-for-your-breasts [9]
February 2013
The New York Times
February 26
Study Sees More Breast Cancer at Young Age – By Denise Grady
The incidence of advanced breast cancer among younger women, ages 25 to 39, may have increased slightly over the last three decades, according to a study released Tuesday. Silvia C. Formenti, MD, questioned the study in part because although it found an increased incidence of advanced disease, it did not find the accompanying increase in deaths that would be expected.
-Silvia C. Formenti, MD, the Sandra and Edward H. Meyer Professor of Radiation Oncology and chair, Department of Radiation Oncology
Read more: http://www.nytimes.com.ezproxy.med.nyu.edu/2013/02/27/health/advanced-breast-cancer-may-be-rising-among-young-women-study-finds.html [10]
Reuters
February 25
Insight: Cancer Drugs Proving Worth Earlier in Testing – By Bill Berkrot and Ransdell Pierson
Typically it took a decade and $1 billion to bring a new treatment to market. But in the last two years a handful of cancer drugs - including Onyx Pharmaceutical Inc's Kyprolis for multiple myeloma, Roche's Zelboraf for melanoma, and Pfizer's Xalkori - were approved in about half that time because of improved genetic screening, more definitive Phase I trials and the need for new, effective treatments. Robert J. Schneider, PhD, is quoted.
-Robert J. Schneider, PhD, the Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology and professor, Department of Radiation Oncology
Read more: http://www.reuters.com/article/2013/02/25/us-cancer-drugs-idUSBRE91O07K20130225 [11]
FierceBiotech.com
February 25
Cancer Drug Developers are Blazing a Faster, Cheaper Path to Approval – By John Carroll
Historically, the business of developing new cancer drugs has been a devastating chronicle of repeated failure.But improvements in sequencing, combined with much better insights on the biologic pathways of cancer and advances in diagnostics, have dramatically improve the odds of success while promising significantly shorter programs at a much lower cost. Robert J. Schneider, PhD, is quoted.
-Robert J. Schneider, PhD, the Albert B. Sabin Professor of Microbiology and Molecular Pathogenesis, Department of Microbiology and professor, Department of Radiation Oncology
Read more: http://www.fiercebiotech.com/story/cancer-drug-developers-are-blazing-faster-cheaper-path-approval/2013-02-25 [12]
Medill Reports Chicago
February 20
Researchers Uncover Genetic Clues to Prevent Cancer Relapse – By Srushti Shah
For the first time, oncology researchers using genomics techniques have identified genetic mutations directly linked to early relapse in children with acute lymphoblastic leukemia [13] (ALL), and have shown that mutations in a particular gene confer resistance to the most commonly used ALL treatment and maintenance therapies. William L. Carroll, MD, is featured.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, professor, Department of Pathology, NYU Cancer Institute
Read more: http://news.medill.northwestern.edu/chicago/news.aspx?id=216189 [14]
Everyday Health
February 17
The Alcoholic-Cancer Link: Even One Drink A Day Could Be Risky – By Amir Khan
Alcohol-related cancer may seem like something that would affect only heavy drinkers, but according to a new study, having even one drink per day can put you at risk for cancer. Freya Schnabel, MD, is quoted.
-Freya R. Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more:
http://www.huffingtonpost.com/2013/02/15/alcohol-cancer-risk-one-drink-light-moderate_n_2694622.html [15]
NYGenome.org
February 15
Genomics Links Mutations to Resistance in Childhood Leukemia – By Joyce Gramza<
For the first time, oncology researchers using genomics techniques have identified genetic mutations directly linked to early relapse in children with acute lymphoblastic leukemia [13] (ALL), and have shown that mutations in a particular gene confer resistance to the most commonly used ALL treatment and maintenance therapies. William L. Carroll, MD, is featured.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, professor, Department of Pathology, NYU Cancer Institute
Read more: http://nygenome.org/blog/genomics-links-mutations-resistance-childhood-leukemia [16]
Health.com
February 14
Cancer Chemotherapy Tied to Slight Rise in Risk for Leukemia – By Mary Elizabeth Dallas, HealthDay News
Chemotherapy can be a lifesaver for thousands of cancer patients, but a new study in the journal Blood suggests that it might slightly raise the odds for a type of leukemia later in life. William Carroll, MD, comments on study.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, professor, Department of Pathology and director, NYU Cancer Institute
Read more:
http://news.health.com/2013/02/14/cancer-chemotherapy-tied-to-slight-rise-in-risk-for-leukemia/ [17]
BioPortfolio
February 11
The WIN Consortium and NYU Cancer Institute Collaborate to Advance Personalized Cancer Care– By Business Wire
NYU Cancer Institute announced that it joined The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine. William Carroll, MD, is quoted.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, professor, Department of Pathology, NYU Cancer Institute
Read more:
http://www.bioportfolio.com/news/article/1319697/The-WIN-Consortium-and-New-York-University-Cancer-Institute-collaborate-to-advance.html [18]
Fort Mill Times
Story also appeared on Financial Post, CBS Marketwatch
February 11
The WIN Consortium and NYU Cancer Institute Collaborate to Advance Personalized Cancer Care– By Business Wire
NYU Cancer Institute announced that it joined The Worldwide Innovative Network (WIN) Consortium in personalized cancer medicine. William Carroll, MD, is quoted.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, professor, Department of Pathology, NYU Cancer Institute
Read more: http://www.fortmilltimes.com/2013/02/11/2489233/the-win-consortium-and-new-york.html [19]
DailyRx
February 11
Finding the Path of No Return for Kids with Cancer – By Robert Carlson, MD
A study at NYU School of Medicine identified acute lymphoblastic leukemia genetic mutations that could potentially lead to ways to predict which patients are likely to relapse. William L. Carroll, MD, is quoted.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, professor, Department of Pathology, NYU Cancer Institute
-Julia Meyer, doctoral student
Read more: http://www.dailyrx.com/acute-lymphoblastic-leukemia-genetic-mutations-linked-relapse-identified [20]
EverydayHealth
February 5
Less-Frequent Mammogram Testing Benefits Older Women – By Erin Hicks
Older women may not need to have a mammogram every year, according to a recent study published in the Journal of the National Cancer Institute. Julia A. Smith, MD, PhD, provides commentary.
-Julia A. Smith, MD, PhD, clinical assistant professor, Department of Medicine, Division of Hematology and Medical Oncology
Read more: http://www.everydayhealth.com/breast-cancer/less-frequent-mammogram-testing-benefits-older-women-8422.aspx [21]
Cancer.gov
February 4
Hope Against Dangerous Form of Acute Lymphoblastic Leukemia
After an intensive three-year hunt through the genome, medical researchers have pinpointed mutations that leads to drug resistance and relapse in the most common type of childhood cancer — the first time anyone has linked the disease’s reemergence to specific genetic anomalies. The discovery, co-lead by William L. Carroll, MD, is reported in a study published online in Nature Genetics.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, Division of Hematology and Medical Oncology, professor, Department of Pathology
Read more: http://www.cancer.gov/newscenter/cancerresearchnews/2013/mutationschildhoodleukemiarelapse [22]
HumanHealthandScience.com
Story also appeared on Bio-Medicine.org, BioPortfolio.com, MedicalXPress.com, BioSpace.com
February 3
Mutations Linked to Relapse Of Childhood Leukemia Discovered
After an intensive three-year hunt through the genome, medical researchers have pinpointed mutations that leads to drug resistance and relapse in the most common type of childhood cancer — the first time anyone has linked the disease’s reemergence to specific genetic anomalies. The discovery, co-lead by William L. Carroll, MD, is reported in a study published online February 3, 2013, in Nature Genetics.
-William L. Carroll, MD, the Julie and Edward J. Minskoff Professor of Pediatrics, Department of Pediatrics, Division of Hematology and Medical Oncology, professor, Department of Pathology
Read more: http://www.humanhealthandscience.com/mutations-linked-to-relapse-of-childhood-leukemia-discovered/general/cancer [23]
January 2013
CBS Evening News
Segment picked up by affiliates in New York, San Francisco, Atlanta, Sacramento, Kansas City, Salt Lake City, Norfolk, Jacksonville, Providence, Tulsa, Toledo and other CBS affiliates
January 28
Mastectomy or Lumpectomy? New Study Could Help Women Decide – By Jonathan LaPook
A new study from researchers at Duke Medicine says patients with early-stage breast cancer who are treated with lumpectomy and radiation have a better chance of survival than women who have a mastectomy. Freya Schnabel, MD, is interviewed with a patient who decided not to undergo a mastectomy.
-Freya R. Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: http://www.cbsnews.com/8301-18563_162-57566311/mastectomy-or-lumpectomy-new-study-could-help-women-decide/ [24]
WCBS New York
Also published by KUTV.com, KVUE.com, Kens5.com, CBS Minnesota
January 28
Study: Lumpectomy Combined With Radiation Could Be Powerful Weapon in Fight Against Breast Cancer – By Hazel Sanchez
Researchers from Duke University recently studied 112,000 women in California who were suffering from early stage breast cancer, and found the patients who received lumpectomies and radiation were 14 percent less likely to die than those who had mastectomies. Freya Schnabel, MD, is interviewed with a patient who decided not to undergo a mastectomy.
-Freya R. Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: [24]http://newyork.cbslocal.com/2013/01/28/study-lumpectomy-combined-with-radiation-could-be-powerful-weapon-in-fight-against-breast-cancer [25]
ABCNews.com
Story also appeared on ITechPost
January 19, 24
Smartphone Apps Can Fall Short in Detecting Skin Cancer, Study Finds – By Dan Childs
Relying on health-care smartphone apps to detect skin cancer can postpone diagnosis and cause harm, a new study has found. Darrell Rigel, MD, is quoted.
-Darrell S. Rigel, MD, clinical professor, Ronald O. Perlman Department of Dermatology
Read more: http://abcnews.go.com/Health/skin-cancer-apps-delay-diagnosis-harm/story?id=18250763 [26]
GymTalkClothing
January 23
Mammograms: What’s Best For Your Breasts?
Last November, the U.S. Preventive Services Task Force (USPSTF) recommended that women swap their after-40 annual mammograms for biannual ones starting at 50, and quit breast self-exams altogether. Karen L. Hiotis, MD, is quoted.
-Karen L. Hiotis, MD, assistant professor, Department of Surgery
Read more: [26]http://www.gymtalkclothing.com/news-and-tips/mammograms-whats-best-for-your-breasts [9]
ABCNews.com
Article also appeared on Yahoo.com, ABCNewsRadio.com, AkronNewsNow.com, Turnto23.com (ABC News by Scripps Media, Inc.)
January 17
Did Doping Cause Lance Armstrong's Cancer? – By Katie Moisse
Now that Armstrong's titles have been tainted by his admitted use of performance-enhancing drugs, questions have also been raised about whether those banned substances caused or contributed to his cancer. The answer is not as clear cut as a confession for cheating. Arjun Vasant Balar, MD, describes how steroids, growth hormones and erythropoietin fuel cell division and growth. Art Caplan, PhD, is also quoted.
-Arjun Vasant Balar, MD, assistant professor, Department of Medicine, Division of Hematology and Medical Oncology
-Arthur L. Caplan, PhD, Drs. William F. and Virginia Connolly Mitty Professor of Bioethics, Department of Population Health, Division of Medical Ethics
Read more: http://abcnews.go.com/Health/lance-armstrongs-livestrong-legacy-stained-doping-cancer-link/story?id=18220378 [27]
Medical News Today
Also covered by NewsMedical.net, MedCompare.com, KenyaStar.com
January 10
H. Pylori May Protect against Stroke and Some Cancers
A new study by NYU School of Medicine researchers reveals that an especially virulent strain of the gut bacterium Helicobacter pylori (H. pylori) isn't implicated in the overall death rate of the U.S. population, and may even protect against stroke and some cancers. The findings, based on a nationwide health survey of nearly 10,000 individuals over a period of 12 years, are published online, January 9, in the journal Gut. Martin Blaser, MD, and Yu Chen, MD, are quoted.
-Martin J. Blaser, MD, professor, Departments of Medicine and Microbiology
-Yu Chen, PhD, MPH, associate professor, Departments of Population Health and Environmental Medicine
Read more: http://www.medicalnewstoday.com/releases/254739.php [28]
Biospace.com
Also picked up by DGNews.com, Human Health and Science, ScienceBlog.com
January 9
Disappearing Bacterium May Protect Against Stroke
A new study by NYU School of Medicine researchers reveals that an especially virulent strain of the gut bacterium Helicobacter pylori (H. pylori) isn't implicated in the overall death rate of the U.S. population, and may even protect against stroke and some cancers. The findings, based on a nationwide health survey of nearly 10,000 individuals over a period of 12 years, are published online, January 9, in the journal Gut.
-Martin J. Blaser, MD, professor, Departments of Medicine and Microbiology
-Yu Chen, PhD, MPH, associate professor, Departments of Population Hhealth and Environmental Medicine
Read more: http://www.biospace.com/News/disappearing-bacterium-may-protect-against-stroke/284297 [29]
Mount Olive Chronicle
January 7
Prayers for Budd Lake Boy Battling Cancer – By Phil Garber
Joey Johnson, a three year old battling brain cancer, is featured in a profile along with his family. He receives regular treatments at the Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders at NYU Langone Medical Center.
-Stephen D. Hassenfeld Children’s Center for Cancer and Blood Disorders at NYU Langone Medical Center
Read more: http://newjerseyhills.com/mt_olive_chronicle/news/prayers-for-budd-lake-boy-battling-cancer/article_3722e856-54de-11e2-b0dc-001a4bcf887a.html [30]
Boston Globe
Story also appeared on MedScape
January 2
Tool OK’d To Help Find All Cancerous Breast Tissue – By Robert Weisman
Federal regulators have approved a new instrument made by Dune Medical Devices Inc. that enables breast cancer surgeons to determine immediately whether they have removed all of the cancer tissue during lumpectomy procedures. Freya Schnabel, MD, is quoted.
-Freya R. Schnabel, MD, professor, Department of Surgery, Division of Breast Surgery
Read more: http://bostonglobe.com/business/2013/01/02/dune-medical-wins-fda-approval-sell-new-breast-cancer-tissue-assessment-tool/km72J2iXqbt2Sv3G0mnHRJ/story.ht [31]